Glen de Vries

Glen de Vries is co-CEO and co-founder of Medidata, the most-used platform for clinical trials around the world. Glen has been driving Medidata’s mission since the company’s inception in 1999, “powering smarter treatments and healthier people” by advancing pharmaceutical business transformation with technology, non-traditional ways of thinking, and industry collaboration. In 2019, in one of the largest health care technology acquisitions in history, Medidata became part of Dassault Systèmes. Glen’s academic publications have appeared in Applied Clinical Trials, Cancer, The Journal of Urology, Molecular Diagnostics, and other journals. He serves as a trustee of Carnegie Mellon University, and is the author of The Patient Equation (de Vries & Blachman, 2020).